Recurrence Patterns and Clinical Management after a Positive Sentinel Node Biopsy in Melanoma Patients.
Cancer Invest
; 41(10): 830-836, 2023 Dec.
Article
en En
| MEDLINE
| ID: mdl-37962565
ABSTRACT
Introduction melanoma patients who become stage III after a positive sentinel node biopsy (SNB) may have several patterns of recurrence patients and methods retrospective analysis of melanoma patients who have undergone SNB in a single institution from 2000 to 2015. Results There were 111 recurrences (45.1%) among 246 (20.3%) SNB positive patients and median DRFS was 77.7 months. After initial treatment, further recurrences occurred in 68 (77.3%) patients, regardless the site of initial recurrence conclusions multimodal strategies are recommended to achieve better results when managing stage III melanoma patients after a positive SNB.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Neoplasias Cutáneas
/
Melanoma
Límite:
Humans
Idioma:
En
Revista:
Cancer Invest
Año:
2023
Tipo del documento:
Article
País de afiliación:
Brasil